{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:08:16Z","timestamp":1776938896767,"version":"3.51.4"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T00:00:00Z","timestamp":1292284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1038\/nrclinonc.2010.196","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T07:24:07Z","timestamp":1292311447000},"page":"97-106","source":"Crossref","is-referenced-by-count":813,"title":["Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways"],"prefix":"10.1038","volume":"8","author":[{"given":"Naoko","family":"Takebe","sequence":"first","affiliation":[]},{"given":"Pamela J.","family":"Harris","sequence":"additional","affiliation":[]},{"given":"Ronald Q.","family":"Warren","sequence":"additional","affiliation":[]},{"given":"S. Percy","family":"Ivy","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,12,14]]},"reference":[{"key":"BFnrclinonc2010196_CR1","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1182\/blood-2008-08-077941","volume":"112","author":"JE Dick","year":"2008","unstructured":"Dick, J. E. Stem cell concepts renew cancer research. Blood 112, 4793\u20134807 (2008).","journal-title":"Blood"},{"key":"BFnrclinonc2010196_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nbt0109-44","volume":"27","author":"JE Dick","year":"2009","unstructured":"Dick, J. E. Looking ahead in cancer stem cell research. Nat. Biotechnol. 27, 44\u201346 (2009).","journal-title":"Nat. Biotechnol."},{"issue":"Suppl. 1","key":"BFnrclinonc2010196_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0959-8049(09)70033-4","volume":"45","author":"HE Johnsen","year":"2009","unstructured":"Johnsen, H. E. et al. Cancer stem cells and the cellular hierarchy in haematological malignancies. Eur. J. Cancer 45 (Suppl. 1), 194\u2013201 (2009).","journal-title":"Eur. J. Cancer"},{"key":"BFnrclinonc2010196_CR4","doi-asserted-by":"publisher","first-page":"6932","DOI":"10.1158\/0008-5472.CAN-07-5779","volume":"68","author":"C Odoux","year":"2008","unstructured":"Odoux, C. et al. A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res. 68, 6932\u20136941 (2008).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1172\/JCI41004","volume":"120","author":"NY Frank","year":"2010","unstructured":"Frank, N. Y., Schatton, T. & Frank, M. H. The therapeutic promise of the cancer stem cell concept. J. Clin. Invest. 120, 41\u201350 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrclinonc2010196_CR6","doi-asserted-by":"publisher","first-page":"11617","DOI":"10.1073\/pnas.0903768106","volume":"106","author":"M McGovern","year":"2009","unstructured":"McGovern, M., Voutev, R., Maciejowski, J., Corsi, A. K. & Hubbard, E. J. A \u201clatent niche\u201d mechanism for tumor initiation. Proc. Natl Acad. Sci. USA 106, 11617\u201311622 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR7","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1073\/pnas.0611682104","volume":"104","author":"CD Peacock","year":"2007","unstructured":"Peacock, C. D. et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc. Natl Acad. Sci. USA 104, 4048\u20134053 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature03319","volume":"434","author":"T Reya","year":"2005","unstructured":"Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843\u2013850 (2005).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/nrc1694","volume":"5","author":"T Brabletz","year":"2005","unstructured":"Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Opinion: migrating cancer stem cells\u2014an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744\u2013749 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"BFnrclinonc2010196_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nature07567","volume":"456","author":"E Quintana","year":"2008","unstructured":"Quintana, E. et al. Efficient tumour formation by single human melanoma cells. Nature 456, 593\u2013598 (2008).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR11","doi-asserted-by":"crossref","unstructured":"Dieter, S. M. et al. Distinct types of human colon cancer initiating cells contribute to primary tumor and metastasis formation [abstract 9]. Proc. Am. Assoc. Cancer Res. (2010).","DOI":"10.1158\/1538-7445.AM10-9"},{"key":"BFnrclinonc2010196_CR12","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1182\/blood-2002-02-0407","volume":"100","author":"M Schmidt","year":"2002","unstructured":"Schmidt, M. et al. Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100, 2737\u20132743 (2002).","journal-title":"Blood"},{"key":"BFnrclinonc2010196_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645\u2013648 (1994).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","volume":"3","author":"D Bonnet","year":"1997","unstructured":"Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730\u2013737 (1997).","journal-title":"Nat. Med."},{"key":"BFnrclinonc2010196_CR15","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M. et al. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983\u20133988 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396\u2013401 (2004).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR17","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1073\/pnas.0703478104","volume":"104","author":"P Dalerba","year":"2007","unstructured":"Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl Acad. Sci. USA 104, 10158\u201310163 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O'Brien","year":"2007","unstructured":"O'Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106\u2013110 (2007).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2007","unstructured":"Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111\u2013115 (2007).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1073\/pnas.0610117104","volume":"104","author":"ME Prince","year":"2007","unstructured":"Prince, M. E. et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 104, 973\u2013978 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann, P. C. et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1, 313\u2013323 (2007).","journal-title":"Cell Stem Cell"},{"key":"BFnrclinonc2010196_CR22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li, C. et al. Identification of pancreatic cancer stem cells. Cancer Res. 67, 1030\u20131037 (2007).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR23","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","volume":"136","author":"T Yamashita","year":"2009","unstructured":"Yamashita, T. et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features. Gastroenterology 136, 1012\u20131024 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrclinonc2010196_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature06489","volume":"451","author":"T Schatton","year":"2008","unstructured":"Schatton, T. et al. Identification of cells initiating human melanomas. Nature 451, 345\u2013349 (2008).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2008.01.013","volume":"13","author":"ZF Yang","year":"2008","unstructured":"Yang, Z. F. et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13, 153\u2013166 (2008).","journal-title":"Cancer Cell"},{"key":"BFnrclinonc2010196_CR26","doi-asserted-by":"publisher","first-page":"16281","DOI":"10.1073\/pnas.0905653106","volume":"106","author":"G Bertolini","year":"2009","unstructured":"Bertolini, G. et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc. Natl Acad. Sci. USA 106, 16281\u201316286 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR27","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang, S. et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68, 4311\u20134320 (2008).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR28","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature08361","volume":"461","author":"X Wang","year":"2009","unstructured":"Wang, X. et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461, 495\u2013500 (2009).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR29","doi-asserted-by":"publisher","first-page":"14016","DOI":"10.1073\/pnas.0906549106","volume":"106","author":"KS Chan","year":"2009","unstructured":"Chan, K. S. et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl Acad. Sci. USA 106, 14016\u201314021 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR30","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1158\/0008-5472.CAN-08-2242","volume":"69","author":"ML Suv\u00e0","year":"2009","unstructured":"Suv\u00e0, M. L. et al. Identification of cancer stem cells in Ewing's sarcoma. Cancer Res. 69, 1776\u20131781 (2009).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR31","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1158\/0008-5472.CAN-08-4418","volume":"69","author":"EH Huang","year":"2009","unstructured":"Huang, E. H. et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69, 3382\u20133389 (2009).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR32","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1158\/0008-5472.CAN-05-4281","volume":"66","author":"Z Wang","year":"2006","unstructured":"Wang, Z. et al. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res. 66, 2778\u20132784 (2006).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature04980","volume":"442","author":"AV Krivtsov","year":"2006","unstructured":"Krivtsov, A. V. et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442, 818\u2013822 (2006).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/35102167","volume":"414","author":"T Reya","year":"2001","unstructured":"Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105\u2013111 (2001).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson, C. H. et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351, 657\u2013667 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2010196_CR36","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.284.5415.770","volume":"284","author":"S Artavanis-Tsakonas","year":"1999","unstructured":"Artavanis-Tsakonas, S., Rand, M. D. & Lake, R. J. Notch signaling: cell fate control and signal integration in development. Science 284, 770\u2013776 (1999).","journal-title":"Science"},{"key":"BFnrclinonc2010196_CR37","doi-asserted-by":"publisher","first-page":"R605","DOI":"10.1186\/bcr920","volume":"6","author":"G Dontu","year":"2004","unstructured":"Dontu, G. et al. Role of Notch signaling in cell-fate determination of human mammary stem\/progenitor cells. Breast Cancer Res. 6, R605\u2013R615 (2004).","journal-title":"Breast Cancer Res."},{"key":"BFnrclinonc2010196_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nature04940","volume":"442","author":"A Androutsellis-Theotokis","year":"2006","unstructured":"Androutsellis-Theotokis, A. et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442, 823\u2013826 (2006).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR39","doi-asserted-by":"publisher","first-page":"32133","DOI":"10.1074\/jbc.M506104200","volume":"280","author":"R Rampal","year":"2005","unstructured":"Rampal, R., Arboleda-Velasquez, J. F., Nita-Lazar, A., Kosik, K. S. & Haltiwanger, R. S. Highly conserved O-fucose sites have distinct effects on Notch1 function. J. Biol. Chem. 280, 32133\u201332140 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrclinonc2010196_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nsmb1227","volume":"14","author":"WR Gordon","year":"2007","unstructured":"Gordon, W. R. et al. Structural basis for autoinhibition of Notch. Nat. Struct. Mol. Biol. 14, 295\u2013300 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnrclinonc2010196_CR41","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm.1900","volume":"15","author":"PJ Real","year":"2009","unstructured":"Real, P. J. et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat. Med. 15, 50\u201358 (2009).","journal-title":"Nat. Med."},{"key":"BFnrclinonc2010196_CR42","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1038\/onc.2008.226","volume":"27","author":"P Rizzo","year":"2008","unstructured":"Rizzo, P. et al. Rational targeting of Notch signaling in cancer. Oncogene 27, 5124\u20135131 (2008).","journal-title":"Oncogene"},{"key":"BFnrclinonc2010196_CR43","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1101\/gad.1239004","volume":"18","author":"A Duarte","year":"2004","unstructured":"Duarte, A. et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 18, 2474\u20132478 (2004).","journal-title":"Genes Dev."},{"key":"BFnrclinonc2010196_CR44","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1073\/pnas.0611177104","volume":"104","author":"S Suchting","year":"2007","unstructured":"Suchting, S. et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc. Natl Acad. Sci. USA 104, 3225\u20133230 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nature05313","volume":"444","author":"J Ridgway","year":"2006","unstructured":"Ridgway, J. et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444, 1083\u20131087 (2006).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR46","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1038\/nature08751","volume":"463","author":"M Yan","year":"2010","unstructured":"Yan, M. et al. Chronic DLL4 blockade induces vascular neoplasms. Nature 463, E6\u2013E7 (2010).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature08543","volume":"462","author":"RE Moellering","year":"2009","unstructured":"Moellering, R. E. et al. Direct inhibition of the NOTCH transcription factor complex. Nature 462, 182\u2013188 (2009).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1747-0285.2008.00744.x","volume":"73","author":"TK Sawyer","year":"2009","unstructured":"Sawyer, T. K. AILERON Therapeutics. Chem. Biol. Drug Des. 73, 3\u20136 (2009).","journal-title":"Chem. Biol. Drug Des."},{"key":"BFnrclinonc2010196_CR49","unstructured":"Epenetos, A., Kousparou, C. & Stylianou, S. Inhibition of Notch signaling for the treatment of human carcinomas. AACR Meeting Abstracts A5502 (2009)."},{"key":"BFnrclinonc2010196_CR50","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/nature08878","volume":"464","author":"Y Wu","year":"2010","unstructured":"Wu, Y. et al. Therapeutic antibody targeting of individual Notch receptors. Nature 464, 1052\u20131057 (2010).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR51","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2001","unstructured":"Ingham, P. W. & McMahon, A. P. Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15, 3059\u20133087 (2001).","journal-title":"Genes Dev."},{"key":"BFnrclinonc2010196_CR52","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","volume":"85","author":"H Hahn","year":"1996","unstructured":"Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841\u2013851 (1996).","journal-title":"Cell"},{"key":"BFnrclinonc2010196_CR53","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","volume":"272","author":"RL Johnson","year":"1996","unstructured":"Johnson, R. L. et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668\u20131671 (1996).","journal-title":"Science"},{"key":"BFnrclinonc2010196_CR54","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nature07275","volume":"455","author":"RL Yauch","year":"2008","unstructured":"Yauch, R. L. et al. A paracrine requirement for hedgehog signalling in cancer. Nature 455, 406\u2013410 (2008).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/dev.129.4.843","volume":"129","author":"CA Micchelli","year":"2002","unstructured":"Micchelli, C. A., The, I., Selva, E., Mogila, V. & Perrimon, N. Rasp, a putative transmembrane acyltransferase, is required for Hedgehog signaling. Development 129, 843\u2013851 (2002).","journal-title":"Development"},{"key":"BFnrclinonc2010196_CR56","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tcb.2007.06.007","volume":"17","author":"A Ruiz i Altaba","year":"2007","unstructured":"Ruiz i Altaba, A., Mas, C. & Stecca, B. The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 17, 438\u2013447 (2007).","journal-title":"Trends Cell Biol."},{"key":"BFnrclinonc2010196_CR57","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/nature02060","volume":"425","author":"AV Molofsky","year":"2003","unstructured":"Molofsky, A. V. et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425, 962\u2013967 (2003).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR58","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.humpath.2008.10.022","volume":"40","author":"AM Adesina","year":"2009","unstructured":"Adesina, A. M. et al. Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum. Pathol. 40, 843\u2013853 (2009).","journal-title":"Hum. Pathol."},{"key":"BFnrclinonc2010196_CR59","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao, C. et al. Hedgehog signaling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458, 776\u2013779 (2009).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR60","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-06-3281","volume":"67","author":"G Feldmann","year":"2007","unstructured":"Feldmann, G. et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 67, 2187\u20132196 (2007).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR61","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/35023008","volume":"406","author":"J Taipale","year":"2000","unstructured":"Taipale, J. et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005\u20131009 (2000).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR62","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2174\/187152006778226495","volume":"6","author":"AS Kiselyov","year":"2006","unstructured":"Kiselyov, A. S. Targeting the hedgehog signaling pathway with small molecules. Anticancer Agents Med. Chem. 6, 445\u2013449 (2006).","journal-title":"Anticancer Agents Med. Chem."},{"key":"BFnrclinonc2010196_CR63","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nrd2086","volume":"5","author":"LL Rubin","year":"2006","unstructured":"Rubin, L. L. & de Sauvage, F. J. Targeting the Hedgehog pathway in cancer. Nat. Rev. Drug Discov. 5, 1026\u20131033 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrclinonc2010196_CR64","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nchembio.142","volume":"5","author":"BZ Stanton","year":"2009","unstructured":"Stanton, B. Z. et al. A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat. Chem. Biol. 5, 154\u2013156 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrclinonc2010196_CR65","doi-asserted-by":"publisher","first-page":"14132","DOI":"10.1073\/pnas.0907134106","volume":"106","author":"JM Hyman","year":"2009","unstructured":"Hyman, J. M. et al. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc. Natl Acad. Sci. USA 106, 14132\u201314137 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR66","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457\u20131461 (2009).","journal-title":"Science"},{"key":"BFnrclinonc2010196_CR67","doi-asserted-by":"publisher","first-page":"a3516","DOI":"10.1200\/jco.2008.26.15_suppl.3516","volume":"26","author":"PM LoRusso","year":"2008","unstructured":"LoRusso, P. M. et al. A first-in-human, first-in-class, phase (ph) I study of systemic Hedgehog (Hh) pathway antagonist, GDC-0449, in patients (pts) with advanced solid tumors [abstract]. J. Clin. Oncol. 26, a3516 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010196_CR68","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","volume":"361","author":"DD Von Hoff","year":"2009","unstructured":"Von Hoff, D. D. et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med. 361, 1164\u20131172 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2010196_CR69","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nrm2717","volume":"10","author":"S Angers","year":"2009","unstructured":"Angers, S. & Moon, R. T. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 10, 468\u2013477 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrclinonc2010196_CR70","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1101\/gad.1686208","volume":"22","author":"T Grigoryan","year":"2008","unstructured":"Grigoryan, T., Wend, P., Klaus, A. & Birchmeier, W. Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. Genes Dev. 22, 2308\u20132341 (2008).","journal-title":"Genes Dev."},{"key":"BFnrclinonc2010196_CR71","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers, H. Wnt\/beta-catenin signaling in development and disease. Cell 127, 469\u2013480 (2006).","journal-title":"Cell"},{"key":"BFnrclinonc2010196_CR72","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.bone.2007.01.005","volume":"40","author":"AC Andrade","year":"2007","unstructured":"Andrade, A. C., Nilsson, O., Barnes, K. M. & Baron, J. Wnt gene expression in the post-natal growth plate: regulation with chondrocyte differentiation. Bone 40, 1361\u20131369 (2007).","journal-title":"Bone"},{"key":"BFnrclinonc2010196_CR73","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.devcel.2006.10.003","volume":"11","author":"R Takada","year":"2006","unstructured":"Takada, R. et al. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev. Cell 11, 791\u2013801 (2006).","journal-title":"Dev. Cell"},{"key":"BFnrclinonc2010196_CR74","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cell.2006.04.018","volume":"125","author":"W Ching","year":"2006","unstructured":"Ching, W. & Nusse, R. A dedicated Wnt secretion factor. Cell 125, 432\u2013433 (2006).","journal-title":"Cell"},{"key":"BFnrclinonc2010196_CR75","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1073\/pnas.96.7.3546","volume":"96","author":"JC Hsieh","year":"1999","unstructured":"Hsieh, J. C., Rattner, A., Smallwood, P. M. & Nathans, J. Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc. Natl Acad. Sci. USA 96, 3546\u20133551 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR76","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.tips.2007.09.001","volume":"28","author":"G Schulte","year":"2007","unstructured":"Schulte, G. & Bryja, V. The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol. Sci. 28, 518\u2013525 (2007).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrclinonc2010196_CR77","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","volume":"95","author":"A de La Coste","year":"1998","unstructured":"de La Coste, A. et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA 95, 8847\u20138851 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR78","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.humpath.2008.06.006","volume":"40","author":"MS Kim","year":"2009","unstructured":"Kim, M. S., Kim, S. S., Ahn, C. H., Yoo, N. J. & Lee, S. H. Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum. Pathol. 40, 58\u201364 (2009).","journal-title":"Hum. Pathol."},{"key":"BFnrclinonc2010196_CR79","first-page":"3880","volume":"59","author":"R Koesters","year":"1999","unstructured":"Koesters, R. et al. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res. 59, 3880\u20133882 (1999).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR80","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1349-7006.2009.01413.x","volume":"101","author":"V Martin","year":"2010","unstructured":"Martin, V. et al. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia. Cancer Sci. 101, 425\u2013432 (2010).","journal-title":"Cancer Sci."},{"key":"BFnrclinonc2010196_CR81","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nature06835","volume":"452","author":"I Malanchi","year":"2008","unstructured":"Malanchi, I. et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature 452, 650\u2013653 (2008).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR82","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1073\/pnas.0900089106","volume":"106","author":"R Majeti","year":"2009","unstructured":"Majeti, R. et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc. Natl Acad. Sci. USA 106, 3396\u20133401 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR83","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1128\/MCB.24.7.2890-2904.2004","volume":"24","author":"C M\u00fcller-Tidow","year":"2004","unstructured":"M\u00fcller-Tidow, C. et al. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol. Cell Biol. 24, 2890\u20132904 (2004).","journal-title":"Mol. Cell Biol."},{"key":"BFnrclinonc2010196_CR84","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nchembio.137","volume":"5","author":"B Chen","year":"2009","unstructured":"Chen, B. et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat. Chem. Biol. 5, 100\u2013107 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrclinonc2010196_CR85","doi-asserted-by":"publisher","first-page":"12682","DOI":"10.1073\/pnas.0404875101","volume":"101","author":"KH Emami","year":"2004","unstructured":"Emami, K. H. et al. A small molecule inhibitor of beta-catenin\/CREB-binding protein transcription [corrected]. Proc. Natl Acad. Sci. USA 101, 12682\u201312687 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrclinonc2010196_CR86","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1158\/1078-0432.CCR-09-2943","volume":"16","author":"F Takahashi-Yanaga","year":"2010","unstructured":"Takahashi-Yanaga, F. & Kahn, M. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin. Cancer Res. 16, 3153\u20133162 (2010).","journal-title":"Clin. Cancer Res."},{"key":"BFnrclinonc2010196_CR87","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1158\/0008-5472.CAN-06-2726","volume":"67","author":"N Fujii","year":"2007","unstructured":"Fujii, N. et al. An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res. 67, 573\u2013579 (2007).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR88","doi-asserted-by":"publisher","first-page":"15495","DOI":"10.1021\/bi0512602","volume":"44","author":"J Shan","year":"2005","unstructured":"Shan, J., Shi, D. L., Wang, J. & Zheng, J. Identification of a specific inhibitor of the dishevelled PDZ domain. Biochemistry 44, 15495\u201315503 (2005).","journal-title":"Biochemistry"},{"key":"BFnrclinonc2010196_CR89","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1038\/sj.onc.1208511","volume":"24","author":"B He","year":"2005","unstructured":"He, B. et al. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 24, 3054\u20133058 (2005).","journal-title":"Oncogene"},{"key":"BFnrclinonc2010196_CR90","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1158\/0008-5472.CAN-04-1227","volume":"64","author":"L You","year":"2004","unstructured":"You, L. et al. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Cancer Res. 64, 5385\u20135389 (2004).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR91","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871\u2013890 (2009).","journal-title":"Cell"},{"key":"BFnrclinonc2010196_CR92","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.mod.2003.06.005","volume":"120","author":"D Shook","year":"2003","unstructured":"Shook, D. & Keller, R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech. Dev. 120, 1351\u20131383 (2003).","journal-title":"Mech. Dev."},{"key":"BFnrclinonc2010196_CR93","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1365-2559.2009.03247.x","volume":"54","author":"MA Kim","year":"2009","unstructured":"Kim, M. A. et al. Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology 54, 442\u2013451 (2009).","journal-title":"Histopathology"},{"key":"BFnrclinonc2010196_CR94","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<271::AID-JCP34>3.0.CO;2-G","volume":"173","author":"M Mareel","year":"1997","unstructured":"Mareel, M. et al. E-cadherin\/catenin\/cytoskeleton complex: a regulator of cancer invasion. J. Cell Physiol. 173, 271\u2013274 (1997).","journal-title":"J. Cell Physiol."},{"key":"BFnrclinonc2010196_CR95","doi-asserted-by":"publisher","first-page":"17259","DOI":"10.1074\/jbc.M700075200","volume":"282","author":"SK Dissanayake","year":"2007","unstructured":"Dissanayake, S. K. et al. The Wnt5A\/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J. Biol. Chem. 282, 17259\u201317271 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrclinonc2010196_CR96","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10585-008-9156-4","volume":"25","author":"E Vincan","year":"2008","unstructured":"Vincan, E. & Barker, N. The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression. Clin. Exp. Metastasis 25, 657\u2013663 (2008).","journal-title":"Clin. Exp. Metastasis"},{"key":"BFnrclinonc2010196_CR97","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massagu\u00e9","year":"2008","unstructured":"Massagu\u00e9, J. TGFbeta in cancer. Cell 134, 215\u2013230 (2008).","journal-title":"Cell"},{"key":"BFnrclinonc2010196_CR98","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","volume":"14","author":"J Yang","year":"2008","unstructured":"Yang, J. & Weinberg, R. A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818\u2013829 (2008).","journal-title":"Dev. Cell"},{"key":"BFnrclinonc2010196_CR99","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/jcb.21509","volume":"102","author":"JM Bailey","year":"2007","unstructured":"Bailey, J. M., Singh, P. K. & Hollingsworth, M. A. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J. Cell Biochem. 102, 829\u2013839 (2007).","journal-title":"J. Cell Biochem."},{"key":"BFnrclinonc2010196_CR100","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/jnci\/djn123","volume":"100","author":"X Li","year":"2008","unstructured":"Li, X. et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl Cancer Inst. 100, 672\u2013679 (2008).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrclinonc2010196_CR101","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1158\/0008-5472.CAN-04-3327","volume":"65","author":"NY Frank","year":"2005","unstructured":"Frank, N. Y. et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 65, 4320\u20134333 (2005).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR102","doi-asserted-by":"publisher","first-page":"7468","DOI":"10.1038\/sj.onc.1206948","volume":"22","author":"SV Ambudkar","year":"2003","unstructured":"Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E. & Gottesman, M. M. P-glycoprotein: from genomics to mechanism. Oncogene 22, 7468\u20137485 (2003).","journal-title":"Oncogene"},{"key":"BFnrclinonc2010196_CR103","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn, M. et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780\u2013783 (2009).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/dvdy.22009","volume":"239","author":"N Itasaki","year":"2010","unstructured":"Itasaki, N. & Hoppler, S. Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev. Dyn. 239, 16\u201333 (2010).","journal-title":"Dev. Dyn."},{"key":"BFnrclinonc2010196_CR105","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbi.2009.09.016","volume":"24","author":"L Sun","year":"2010","unstructured":"Sun, L., Tian, Z. & Wang, J. A direct cross-talk between interferon-gamma and sonic hedgehog signaling that leads to the proliferation of neuronal precursor cells. Brain Behav. Immun. 24, 220\u2013228 (2010).","journal-title":"Brain Behav. Immun."},{"key":"BFnrclinonc2010196_CR106","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev.genet.40.110405.090555","volume":"40","author":"P Vivekanand","year":"2006","unstructured":"Vivekanand, P. & Rebay, I. Intersection of signal transduction pathways and development. Annu. Rev. Genet. 40, 139\u2013157 (2006).","journal-title":"Annu. Rev. Genet."},{"key":"BFnrclinonc2010196_CR107","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1172\/JCI37964","volume":"120","author":"J Ma","year":"2010","unstructured":"Ma, J. et al. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3\/p63\/Jagged\/Notch cascade. J. Clin. Invest. 120, 103\u2013114 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrclinonc2010196_CR108","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jcb.22451","volume":"109","author":"Z Wang","year":"2010","unstructured":"Wang, Z. et al. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J. Cell. Biochem. 109, 726\u2013736 (2010).","journal-title":"J. Cell. Biochem."},{"key":"BFnrclinonc2010196_CR109","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1158\/0008-5472.CAN-08-3478","volume":"69","author":"O Meurette","year":"2009","unstructured":"Meurette, O. et al. Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res. 69, 5015\u20135022 (2009).","journal-title":"Cancer Res."},{"key":"BFnrclinonc2010196_CR110","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/07357900802563036","volume":"27","author":"J Dai","year":"2009","unstructured":"Dai, J. et al. Cross-talk between Notch and EGFR signaling in human breast cancer cells. Cancer Invest. 27, 533\u2013540 (2009).","journal-title":"Cancer Invest."},{"key":"BFnrclinonc2010196_CR111","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/carcin\/bgn079","volume":"29","author":"BW Purow","year":"2008","unstructured":"Purow, B. W. et al. Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Carcinogenesis 29, 918\u2013925 (2008).","journal-title":"Carcinogenesis"},{"key":"BFnrclinonc2010196_CR112","first-page":"1341","volume":"9","author":"SP Deb","year":"1994","unstructured":"Deb, S. P., Mu\u00f1oz, R. M., Brown, D. R., Subler, M. A. & Deb, S. Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9, 1341\u20131349 (1994).","journal-title":"Oncogene"},{"key":"BFnrclinonc2010196_CR113","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1056\/NEJMoa051918","volume":"353","author":"IK Mellinghoff","year":"2005","unstructured":"Mellinghoff, I. K. et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N. Engl. J. Med. 353, 2012\u20132024 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2010196_CR114","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1038\/onc.2008.149","volume":"27","author":"C Osipo","year":"2008","unstructured":"Osipo, C. et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene 27, 5019\u20135032 (2008).","journal-title":"Oncogene"},{"key":"BFnrclinonc2010196_CR115","first-page":"35","volume":"23","author":"H Hirose","year":"2010","unstructured":"Hirose, H. et al. Notch pathway as candidate therapeutic target in Her2\/Neu\/ErbB2 receptor-negative breast tumors. Oncol. Rep. 23, 35\u201343 (2010).","journal-title":"Oncol. Rep."},{"key":"BFnrclinonc2010196_CR116","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2008.302","volume":"19","author":"X Guo","year":"2009","unstructured":"Guo, X. & Wang, X. F. Signaling cross-talk between TGF-beta\/BMP and other pathways. Cell Res. 19, 71\u201388 (2009).","journal-title":"Cell Res."},{"key":"BFnrclinonc2010196_CR117","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.emboj.7600069","volume":"23","author":"J Zavadil","year":"2004","unstructured":"Zavadil, J., Cermak, L., Soto-Nieves, N. & B\u00f6ttinger, E. P. Integration of TGF-beta\/Smad and Jagged1\/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 23, 1155\u20131165 (2004).","journal-title":"EMBO J."},{"key":"BFnrclinonc2010196_CR118","doi-asserted-by":"publisher","first-page":"35598","DOI":"10.1074\/jbc.C600200200","volume":"281","author":"J He","year":"2006","unstructured":"He, J. et al. Suppressing Wnt signaling by the hedgehog pathway through sFRP-1. J. Biol. Chem. 281, 35598\u201335602 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrclinonc2010196_CR119","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.bbadis.2009.02.007","volume":"1792","author":"VJ Bhagwandin","year":"2009","unstructured":"Bhagwandin, V. J. & Shay. J. W. Pancreatic cancer stem cells: fact or fiction? Biochim. Biophys. Acta 1792, 248\u2013259 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrclinonc2010196_CR120","doi-asserted-by":"crossref","first-page":"a6585","DOI":"10.1200\/jco.2006.24.18_suppl.6585","volume":"24","author":"DJ Deangelo","year":"2006","unstructured":"Deangelo, D. J. et al. A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia\/lymphoma (T-ALL) and other leukemias [abstract]. J. Clin. Oncol. 24, a6585 (2006).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010196_CR121","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1016\/j.bmcl.2007.07.078","volume":"17","author":"JU Peters","year":"2007","unstructured":"Peters, J. U. et al. Novel orally active, dibenzazepinone-based gamma-secretase inhibitors. Bioorg Med. Chem. Lett. 17, 5918\u20135923 (2007).","journal-title":"Bioorg Med. Chem. Lett."},{"key":"BFnrclinonc2010196_CR122","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrm1406","volume":"5","author":"R Kopan","year":"2004","unstructured":"Kopan, R. & Ilagan, M. X. Gamma-secretase: proteasome of the membrane? Nat. Rev. Mol. Cell Biol. 5, 499\u2013504 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrclinonc2010196_CR123","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1074\/jbc.M800170200","volume":"283","author":"K Li","year":"2006","unstructured":"Li, K. et al. Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3. J. Biol. Chem. 283, 8046\u20138054 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrclinonc2010196_CR124","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.stem.2009.05.019","volume":"5","author":"T Hoey","year":"2009","unstructured":"Hoey, T. et al. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 5, 168\u2013177 (2009).","journal-title":"Cell Stem Cell"},{"key":"BFnrclinonc2010196_CR125","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/nature05355","volume":"444","author":"I Noguera-Troise","year":"2006","unstructured":"Noguera-Troise, I. et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444, 1032\u20131037 (2006).","journal-title":"Nature"},{"key":"BFnrclinonc2010196_CR126","doi-asserted-by":"publisher","first-page":"29729","DOI":"10.1074\/jbc.272.47.29729","volume":"272","author":"C Garc\u00e9s","year":"1997","unstructured":"Garc\u00e9s, C. et al. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J. Biol. Chem. 272, 29729\u201329734 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrclinonc2010196_CR127","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/sj.cdd.4401036","volume":"9","author":"BJ Nickoloff","year":"2002","unstructured":"Nickoloff, B. J. et al. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ. 9, 842\u2013855 (2002).","journal-title":"Cell Death Differ."},{"key":"BFnrclinonc2010196_CR128","doi-asserted-by":"publisher","first-page":"315","DOI":"10.6004\/jnccn.2008.0026","volume":"6","author":"CM Rudin","year":"2008","unstructured":"Rudin, C. M., Hann, C. L., Peacock, C. D. & Watkins, D. N. Novel systemic therapies for small cell lung cancer. J. Natl Compr. Canc. Netw. 6, 315\u2013322 (2008).","journal-title":"J. Natl Compr. Canc. Netw."},{"key":"BFnrclinonc2010196_CR129","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10549-009-0423-0","volume":"116","author":"MF Barginear","year":"2009","unstructured":"Barginear, M. F., Leung, M. & Budman, D. R. The hedgehog pathway as a therapeutic target for treatment of breast cancer. Breast Cancer Res. Treat. 116, 239\u2013246 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFnrclinonc2010196_CR130","first-page":"1975","volume":"47","author":"C Fukukawa","year":"2006","unstructured":"Fukukawa, C. Katagiri, T., Nakatsuru, S. & Nakamura, Y. Therapeutic potential of antibodies against frizzled homologue 10, a cell-surface protein, for synovial sarcoma [abstract]. Proc. Amer. Assoc. Cancer Res. 47, 1975 (2006).","journal-title":"Proc. Amer. Assoc. Cancer Res."},{"key":"BFnrclinonc2010196_CR131","first-page":"631","volume":"25","author":"T Yoshizumi","year":"2004","unstructured":"Yoshizumi, T. et al. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Int. J. Oncol. 25, 631\u2013639 (2004).","journal-title":"Int. J. Oncol."},{"key":"BFnrclinonc2010196_CR132","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1056\/NEJMoa061652","volume":"355","author":"N Arber","year":"2006","unstructured":"Arber, N. et al. Celecoxib for the prevention of colorectal adenomatous polyps. N. Engl. J. Med. 355, 885\u2013895 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc2010196_CR133","first-page":"78","volume":"6","author":"R van Stolk","year":"2000","unstructured":"van Stolk, R. et al. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin. Cancer Res. 6, 78\u201389 (2000).","journal-title":"Clin. Cancer Res."},{"key":"BFnrclinonc2010196_CR134","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2199-4-10","volume":"4","author":"F Cong","year":"2003","unstructured":"Cong, F., Zhang, J., Pao, W., Zhou, P. & Varmus, H. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol. Biol. 4, 10 (2003).","journal-title":"BMC Mol. Biol."},{"key":"BFnrclinonc2010196_CR135","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.bbrc.2003.12.035","volume":"313","author":"J Liu","year":"2004","unstructured":"Liu, J., Stevens, J., Matsunami, N. & White, R. L. Targeted degradation of beta-catenin by chimeric F-box fusion proteins. Biochem. Biophys. Res. Commun. 313, 1023\u20131029 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrclinonc2010196_CR136","first-page":"1081","volume-title":"50th ASH Annual Meeting and Exposition Abstracts","author":"R Nagao","year":"2008","unstructured":"Nagao, R. et al. A novel \u03b2-catenin inhibitor, AV65 suppresses the growth of CML cell lines which acquire imatinib-resistance because of Abl kinase domain mutations including T315I and hypoxia-adaptation. 50th ASH Annual Meeting and Exposition Abstracts, 1081 (2008)."},{"key":"BFnrclinonc2010196_CR137","doi-asserted-by":"publisher","first-page":"12729","DOI":"10.1073\/pnas.2133261100","volume":"100","author":"Y Su","year":"2003","unstructured":"Su, Y., Ishikawa, S., Kojima, M. & Liu, B. Eradication of pathogenic beta-catenin by Skp1\/Cullin\/F box ubiquitination machinery. Proc. Natl Acad. Sci. USA 100, 12729\u201312734 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.196","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T20:34:23Z","timestamp":1712003663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2010.196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,14]]},"references-count":137,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["BFnrclinonc2010196"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2010.196","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10022957.10762055","asserted-by":"object"}]},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,14]]}}}